AYTU BIOPHARMA, INC Form DEF 14C: Definitive information statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-06-22: Form DEF 14C; Period of report 2015-06-22; Description DEF 14C; Document d943871ddef14c.htm.
- 2011-02-24: Form DEF 14C; Period of report 2011-02-22; Description Definitive information statement; Document rosewinddef124c_2242011.htm.
- 2010-07-09: Form DEF 14C; Period of report 2010-07-12; Description ROSEWIND CORPORATION DEFINITIVE 14C INFO STMT; Document defis14c.txt.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2015-06-22 | DEF 14C | 2015-06-22 | DEF 14C | d943871ddef14c.htm |
| 2011-02-24 | DEF 14C | 2011-02-22 | Definitive information statement | rosewinddef124c_2242011.htm |
| 2010-07-09 | DEF 14C | 2010-07-12 | ROSEWIND CORPORATION DEFINITIVE 14C INFO STMT | defis14c.txt |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |